Trending Articles

US plans shift to private market sales of COVID-19 vaccines, drugs

Bio Pharma Dive

The federal government will begin the transition as early as this fall, clearing the way for drugmakers to control sales and distribution of their shots and therapeutics

Sales 178

Obesity: Is killing us all

World of DTC Marketing

The new Inflation Bill will not reduce healthcare costs in the U.S. An analysis predicts that by 2030, 48.9% of adults in the United States will be obese, and 24.2% will be severely obese.

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Bristol Myers claims success in study testing earlier CAR-T use in multiple myeloma

Bio Pharma Dive

Abecma, which 2Seventy bio helps develop and sell, is currently approved for patients who have tried at least four other medicines for the blood cancer

Why DTC isn’t, and is, marketing

World of DTC Marketing

CPG marketers are trying to maintain market share amid price increases and smaller product sizes, leading to a more significant jump in consumerism. But, in pharma marketing, the changes affect every product category.

2022 Research: The Rapid Rise of Ocean Freight Visibility

Download this a benchmark study from FourKites and The Journal of Commerce exploring how international shippers’ usage of global supply chain visibility technology has evolved since the onset of global disruptions caused by COVID-19.

UK health data collaboration paves the way to study long Covid symptoms

Pharmaceutical Technology

If the last two years have taught us anything, it’s that healthcare challenges transcend nations.

The fight is on: As US pricing reform advances through Congress, pharma gears up for a brawl

Fierce Pharma

The fight is on: As US pricing reform advances through Congress, pharma gears up for a brawl. fkansteiner. Thu, 08/11/2022 - 10:30

99

More Trending

GentiBio partners with Bristol Myers as cell therapy for immune disease gains momentum

Bio Pharma Dive

The deal, worth as much as $2 billion, is the latest sign of industry interest in treatments that harness regulatory T cells, an approach behind several recent biotech startups

249
249

PhRMA lies to protect pharma profits

World of DTC Marketing

PhRMA is lying to protect its profits, and the lies have reached a new height as the Senate moved to adopt modest drug pricing negotiation measures in the Inflation Reduction Act.

FDA grants Fast-Track status for Relmada’s major depressive disorder therapy

Pharmaceutical Technology

The US Food and Drug Administration (FDA) has granted Fast-Track designation to Relmada Therapeutics’ REL-1017 as a single agent to treat major depressive disorder (MDD).

In needed boon for Gilead, Trodelvy chalks up surprise breast cancer survival win

Fierce Pharma

In needed boon for Gilead, Trodelvy chalks up surprise breast cancer survival win. Mon, 08/15/2022 - 14:24

83

An Innovative & Creative Problem Solver Approach to Selling in the Medical Device Space

Speaker: Steve Goldstein, Sales Leader

Currently in sales or involved in a business that depends on strong sales results? Join Steve Goldstein, Sales Success Coach, Motivational Speaker and Medical Device Sales Leader from Gold Selling LLC. You will absorb critical strategies to become a trusted partner in greater sales success.

A Dive into ULT

Pharmaceutical Commerce

Thermo Fisher’s Dean Rainbolt on how ultra low-temperature freezers are continuing to change the game.

52

Messaging the right HCP at the right time via their electronic health record (EHR)

Bio Pharma Dive

HCPs spend 3x the time in their EHR each day as they do online. How should that affect your approach to reaching HCPs

208
208

Brexit fallout continues with batch testing concerns

Pharmaceutical Technology

More than a year and a half after the Brexit deal came into effect, the UK’s pharmaceutical industry is still trying to determine the likely impacts.

Versant bets $30M on next-gen gene delivery startup Vector

Fierce Pharma

Versant bets $30M on next-gen gene delivery startup Vector. ntaylor. Mon, 08/15/2022 - 08:47

Gene 83

Mandatory COVID Vaccination Policy Template

The federal government is developing a rule requiring employers with more than 100 employees ensure their workers are vaccinated or produce a negative COVID test weekly before entering the workplace. So, what can your organization do to prepare? Get Paycor’s COVID Vaccination Policy Template to help communicate important details to your employees.

A Saga of 75 years journey of Indian Pharmaceutical Industry

Pharmatutor

A Saga of 75 years journey of Indian Pharmaceutical Industry. Look back of growth drive for Indian pharmaceutical industry after 75 years of independence and future roadmap. admin. Sun, 08/14/2022 - 18:21. Pharmapedia. Articles.

83

What to look for when hiring in pharma

World of DTC Marketing

The great resignation has not affected pharma because the jobs within the industry pay very well and most positions and employees like the benefit of having a steady job with good money.

FDA makes moves to advance ALS research ahead of upcoming Amylyx AdCom

Pharmaceutical Technology

In the lead-up to a critical meeting that will influence the approval of a new drug for amyotrophic lateral sclerosis (ALS), the US Food and Drug Administration (FDA) has detailed its plans to advance rare neurodegenerative disease research.

With Pfizer, AZ and Merck leading the way, Big Pharma weathered the economic storm in Q2

Fierce Pharma

With Pfizer, AZ and Merck leading the way, Big Pharma weathered the economic storm in Q2. kdunleavy. Mon, 08/15/2022 - 08:35

83

GSK, Sanofi and Haleon ‘facing billions of dollars in Zantac liability’

pharmaphorum

GSK, its consumer health spin-off Haleon and Sanofi could be on the hook for billions of dollars in potential damages over Zantac, a gastrointestinal drug pulled from the market in 2020 after it was linked to cases of cancer.

Gemini’s fall gives Disc a way around biotech’s IPO slump

Bio Pharma Dive

The biotech’s failed attempt to develop an eye disease drug has ended in a reverse merger that gives startup Disc Medicine a fast path to the public markets

Can we be serious about telehealth?

World of DTC Marketing

If you follow the hype around telehealth, you would think it will save healthcare. Telehealth does have a future as PART of healthcare, but it won’t replace the benefit of seeing a patient in person and being able to diagnose a health problem. There it is again.

US FDA approves Daiichi Sankyo-AstraZeneca’s Enhertu for lung cancer

Pharmaceutical Technology

The US Food and Drug Administration (FDA) has granted approval for Daiichi Sankyo and AstraZeneca ’s Enhertu (fam-trastuzumab deruxtecan-nxki) to treat unresectable or metastatic non-small cell lung cancer (NSCLC) in adults.

Third time is not always the charm: Novartis's Ilaris flops⁠—again⁠—in lung cancer

Fierce Pharma

Third time is not always the charm: Novartis's Ilaris flops?—again?—in again?—in in lung cancer. zbecker. Mon, 08/15/2022 - 11:01

83

Lynparza in combination with abiraterone granted Priority Review in the US for patients with metastatic castration-resistant prostate cancer

The Pharma Data

First PARP asset to demonstrate clinical benefit in combination with a new hormonal agent irrespective of homologous recombination form( HRR) gene mutations.

DNA 52

GSK, Pfizer, Sanofi shares drop amid Zantac litigation concerns

Bio Pharma Dive

The companies could face liability related to their sales of the heartburn drug, which was withdrawn from market in the U.S. and other countries after impurities related to a likely carcinogen were detected

Sales 222

FDA Inspections Back Up To Speed (Except Those Now Deemed Unnecessary)

FDA Law Blog

By Douglas B. Farquhar — Those of us who work frequently on FDA inspections of drug and medical device manufacturing facilities have noticed an uptick in regular inspections after a dramatic falloff during the first two years of COVID.

The potential of virtual reality-based therapy for serious mental disorders

Pharmaceutical Technology

In June this year, it was announced that the US Food and Drug Administration (FDA) had granted UK-based OxfordVR a breakthrough device designation for its gameChangeVR treatment to deliver immersive cognitive behaviour therapy (CBT) to people suffering from schizophrenia and other mental illnesses.

AstraZeneca and Daiichi's Enhertu winning streak rolls on with confirmatory trial victory in advanced breast cancer

Fierce Pharma

AstraZeneca and Daiichi's Enhertu winning streak rolls on with confirmatory trial victory in advanced breast cancer. fkansteiner. Mon, 08/15/2022 - 11:09

FDA accepts supplemental Biologics License Application for Roche’s Polivy combination for people with previously untreated diffuse large B-cell lymphoma

The Pharma Data

Novartis reports deaths of two patients treated with Zolgensma gene therapy

Bio Pharma Dive

The deaths were due to acute liver injury, a known risk of Zolgensma and a concern for gene therapies like it

Are You a Veteran? How the PACT Act May Help You.

Triage Cancer

The PACT Act is a new law that expands health care and other benefits for Veterans exposed to burn pits and other toxic substances while serving in the military.

Cerevance and Merck partner to detect new Alzheimer’s targets

Pharmaceutical Technology

Cerevance has entered a multi-year strategic research partnership with Merck (MSD outside North America) to discover new targets for Alzheimer’s disease.

Armed with $570M war chest, Arcutis launches psoriasis cream in the US

Fierce Pharma

Armed with $570M war chest, Arcutis launches psoriasis cream in the US. ntaylor. Mon, 08/15/2022 - 08:44

82

FDA Finalizes Historic Rule Enabling Access to Over-the-Counter Hearing Aids for Millions of Americans

The Pharma Data

Today, the U.S. Food and Drug Administration issued a final rule to improve access to hearing aids which may in turn lower costs for millions of Americans.